Don't have an account?
Defying time
Revolution™ EVO Gen 3 defies time by helping you surpass your day-to-day challenges at every step of the care cycle.
The challenge
Optimize time of teams and patients, as well as calculate the right radiation dose for the right patient while delivering the right image quality.
ASiR™ or ASiR-V*™1,
ASiR™, the world’s most-used iterative reconstruction (IR) method, and ASiR-V*, the next generation of GE iterative reconstruction technique, allow you to routinely lower the exam dose while preserving or even enhancing diagnostic value.
150+ Patient-size adjusted, dose optimized protocols (UW)
Designed, developed, and validated by experts at the University of Wisconsin-Madison, for GE scanners for both adults and pediatrics.
2 400 000+ exams collected with DoseWatch Explore*
Web-based, cloud-deployed solution to track, analyze, and report practice-level dose data. Getting started with dose management has never been easier.
Keeping your hospital systems up and running is critical to your ability to deliver efficient, high-quality patient care. Tube Watch is GE Healthcare’s predictive monitoring solution for CT scanners that can help predict an impending tube failure, enabling tube replacement at a more convenient time.
*Optional
1. In clinical practice, the use of ASiR or * may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. For ASiR-V*, Low contrast detectability (LCD), image noise, spatial resolution and artifacts were assessed using reference factory protocols comparing ASiR-V* and FBP. The LCD measured in 0.625 mm slices and tested for both head and body modes using the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using model observer method.
2. SnapShot Freeze requires CardIQ Xpress 2.0 Reveal on AW or AW Server.
3. 20% decrease of mean reading time during a typical working period (07:00am-07:00pm).
4. Some of the technologies herein are technologies in development that represent ongoing research and development efforts. These technologies are not products and may never become products. Not for sale. Some products are not cleared or approved by FDA and/or some other countries for commercial availability.
5. As demonstrated in cardiac phantom testing.
6. DLIR neural networks give an image appearance (as shown on NPS plots) similar to traditional high-dose, low-noise FBP images. Demonstrated in phantom testing comparing images reconstructed from the same raw data, with DLIR-H and ASiR-V 50%, using the standard kernel.
7. The products mentioned in this material may not be available in all markets. Consult with your sales representative.
8. Not yet CE marked. May not be available for sale in all countries. DLIR neural networks give an image appearance (as shown on NPS plots) similar to traditional high-dose, low-noise FBP images. Demonstrated in phantom testing comparing images reconstructed from the same raw data, with DLIR-H and ASiR-V 50%, using the standard kernel.
9. Local regulations and/or validations may affect product availability, so some products may not be available for sale in all countries. Before placing an order, check with your GE sales or customer service representative on product availability.